Jane Street’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,300
Closed -$296K 9875
2023
Q1
$296K Sell
8,300
-66,100
-89% -$2.4M ﹤0.01% 7223
2022
Q4
$2.73M Buy
+74,400
New +$2.94M ﹤0.01% 3368
2020
Q3
Sell
-49,900
Closed -$2.91M 8167
2020
Q2
$2.91M Buy
+49,900
New +$2.68M ﹤0.01% 2556

Other funds holding SYNH

Jane Street's SYNH Position: Q3 2023 in Review

Jane Street sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 449,573 shares — an estimated $18.9M sold.

Jane Street first reported a position in SYNH in Q3 2017 and held it in 19 quarters. The position peaked at $18.9M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Jane Street reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 449,573 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $18.9M.
  • Jane Street first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 19 quarters.
  • Jane Street's Syneos Health, Inc. Class A Common Stock position peaked at $18.9M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.